GLSI · Greenwich LifeSciences, Inc.
$14.02
+1.22 (+9.53%)
At close · Jul 30
Going-concern doubt
— flagged Jun 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has incurred net losses since its inception and has negative operating cash flows. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed Jun 4, 2026
Market Cap
$205.79M
Shares
14.68M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
Key facts
CIK
1799788
CUSIP
396879108
13F (30d)
10 filings
10 filers
Visit website
Investor relations